Customer Notification Letter (PDF:151KB)
Effective April 30, 2021, PERSOL PHARMA PARTNERS CO.,LTD. is now a subsidiary of Syneos Health
Clinical K.K., a full-service CRO in Japan (including ICCC andPMDA/Regulatory Consultation),
offering therapeutic expertise,local expertise andoperational excellence. For more information,
please visit Syneos Health.
PERSOL PHARMA PARTNERS CO.,LTD.
Syneos Pharma Partners Co., Ltd.
PV NEXT and MEDICROSS merged to become PERSOL PHARMA PARTNERS CO., LTD.